WHO, UNAIDS, UNICEF: Global HIV/AIDS Response. Epidemic Update and Health Sector Progress towards Universal Access. Progress Report 2011. 2011
UNAIDS: UNAIDS report on the global AIDS epidemic 2013. 2013, Available at http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf (accessed September 2014)
Ministry of Health of Ukraine: Ukraine Harmonized AIDS Response Progress Report. Reporting Period: January 2010 - December 2011. 2012, Kiev, Ukraine: Ministry of Health of Ukraine
WHO: Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Their Infants: Recommendations for a Public Health Approach. 2010 Version. 2010, Geneva, Switzerland: World Health Organization
Bailey H, Townsend CL, Semenenko I, Malyuta R, Cortina-Borja M, Thorne C, Ukraine European Collaborative Study Group in E: Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine. Bull World Health Organ. 2013, 91 (7): 491-500. 10.2471/BLT.12.114405.
Ministry of Health of Ukraine: Ukraine: National Report on Monitoring Progress Towards the UNGASS Declaration of Commitment on HIV/AIDS, January 2008-December 2009. 2010, Kiev: Ministry of Health of Ukraine
Gross R, Yip B, Lo Re V, Wood E, Alexander CS, Harrigan PR, Bangsberg DR, Montaner JSG, Hogg RS: A simple dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006, 194: 1108-1114. 10.1086/507680.
Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JSG: Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS. 2008, 22: 2371-2380. 10.1097/QAD.0b013e328315cdd3.
Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, Yip B, Montaner JSG: The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009, 50 (5): 529-536. 10.1097/QAI.0b013e31819675e9.
Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L, ANRS French Perinatal Cohort: Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS french perinatal cohort. AIDS. 2008, 22 (2): 289-299. 10.1097/QAD.0b013e3282f3d63c.
Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA: Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS. 2008, 22 (8): 973-981. 10.1097/QAD.0b013e3282f9b67a.
Desai N, Mathur M: Selective transmission of multidrug resistant HIV to a newborn related to poor maternal adherence. Sex Transm Infect. 2003, 79: 419-421. 10.1136/sti.79.5.419.
Mellins CA, Chu C, Malee K, Allison S, Smith R, Harris L, Higgins A, Zorrilla C, Landesman S, Serchuck L, Larussa P: Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care. 2008, 20 (8): 958-968. 10.1080/09540120701767208.
Cohn SE, Umbleja T, Mrus J, Bardeguez AD, Andersen JW, Chesney MA: Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084. AIDS Patient Care STDS. 2008, 22 (1): 29-40. 10.1089/apc.2007.0053.
Kingston MA, Letham CJ, McQuillan O: Adherence to antiretroviral therapy in pregnancy. Int J STD AIDS. 2007, 18 (11): 787-789. 10.1258/095646207782212216.
Turner BJ, Newschaffer CJ, Zhang D, Cosler L, Hauck WW: Antiretroviral Use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care. 2000, 38 (9): 911-925. 10.1097/00005650-200009000-00005.
Laine C, Newschaffer CJ, Zhang D, Cosler L, Hauck WW, Turner BJ: Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet Gynecol. 2000, 95 (2): 167-173. 10.1016/S0029-7844(99)00523-2.
Minozzi S, Amato L, Vecchi S, Davoli M: Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev. 2008, 16 (2): CD006318-
Judice N, Zaglada O, Mbuya-Brown R: HIV Policy Assessment: Ukraine. 2011, Washington, DC: Futures Group, Health Policy Project
Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, Mills EJ, Ho YS, Stringer JS, McIntyre JA, Mofenson LM: Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis. AIDS. 2012, 26 (16): 2039-2052. 10.1097/QAD.0b013e328359590f.
Vaz MJ, Barros SM, Palacios R, Senise JF, Lunardi L, Amed AM, Castelo A: HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. Int J STD AIDS. 2007, 18: 28-32. 10.1258/095646207779949808.
Bardeguez AD, Lindsey JC, Shannon M, Tuomala RE, Cohn SE, Smith E, Stek A, Buschur S, Cotter A, Bettica L, Read JS: Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr. 2008, 48 (4): 408-417. 10.1097/QAI.0b013e31817bbe80.
Ickovics JR, Wilson TE, Royce RA, Minkoff HL, Fernandez MI, Fox-Tierney R, Koenig LJ: Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. J Acquir Immune Defic Syndr. 2002, 30 (3): 311-315. 10.1097/00126334-200207010-00007.
Bailey H, Thorne C, Semenenko I, Malyuta R, Tereschenko R, Adeyanova I, Kulakovskaya E, Ostrovskaya L, Kvasha L, Cortina-Borja M, Townsend CL: Cervical screening within HIV care: findings from an HIV-positive cohort in Ukraine. PLoS One. 2012, 7 (4): e34706-10.1371/journal.pone.0034706.
AIDS Clinical Trials Group: Center for AIDS prevention studies (CAPS) instruments: ACTG adherence baseline questionnaire. 2010, Accessed September 2012. http://caps.ucsf.edu/uploads/tools/surveys/pdf/2098.4186.pdf
NIAID Adult AIDS Clinical Trials Group: Supplemental antepartum adherence questionnaire. 2001, Accessed August 2014. Available at https://www.fstrf.org/apps/cfmx/apps/common/QOLAdherenceForms/index.cfm?project=ACTG
Mannheimer SB, Mukherjee R, Hirschhorn LR, Dougherty J, Celano SA, Ciccarone D, Graham KK, Mantell JE, Mundy LM, Eldred L, Botsko M, Finkelstein R: The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy. AIDS Care. 2006, 18 (7): 853-861. 10.1080/09540120500465160.
Kerr SJ, Avihingsanon A, Putcharoen O, Chetchotisakd P, Layton M, Ubolyam S, Ruxrungtham K, Cooper DA, Phanuphak P, Duncombe C: Assessing adherence in Thai patients taking combination antiretroviral therapy. Int J STD AIDS. 2012, 23 (3): 160-165. 10.1258/ijsa.2009.009152.
Apisarnthanarak A, Mundy LM: Application of a 3-item adherence metric to monitor antiretroviral medication adherence in a resource-limited setting. J Acquir Immune Defic Syndr. 2010, 55 (4): 528-10.1097/QAI.0b013e3181eec0c4.
Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA: Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006, 10: 227-245. 10.1007/s10461-006-9078-6.
Whooley MA, Avins AL, Miranda J, Browner WS: Case-finding instruments for depression: two questions are as good as many. J Gen Intern Med. 1997, 12: 439-445. 10.1046/j.1525-1497.1997.00076.x.
Arroll B, Goodyear-Smith F, Kerse N, Fishman T, Gunn J: Effect of the addition of a “help” question to two screening questions on specificity for diagnosis of depression in general practice: diagnostic validity study. BMJ. 2005, 331 (7521): 884-10.1136/bmj.38607.464537.7C.
AIDS Clinical Trials Group: Center for AIDS Prevention Studies (CAPS) instruments: the HIV treatment adherence self-efficacy scale. 2010, Accessed September 2012. http://caps.ucsf.edu/uploads/tools/surveys/pdf/HIV-ASES.pdf
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG: Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009, 42 (2): 377-381. 10.1016/j.jbi.2008.08.010.
Bangsberg DR, Hecht FM, Charlebois ED, Zolopa A, Holodniy M, Sheiner L, Bamberger JD, Chesney MA, Moss A: Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000, 14: 357-366. 10.1097/00002030-200003100-00008.
Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, Christian JMT, Duran D, Kaplan AH, Wenger NS: A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001, 134: 968-977. 10.7326/0003-4819-134-10-200105150-00011.
Kimmerling M, Wagner G, Ghosh-Dastidar B: Factors associated with accurate self-reported adherence to HIV antiretrovirals. Int J STD AIDS. 2003, 14: 281-284. 10.1258/095646203321264917.
WHO: Consolidated Guidelines on the use of Antiretroviral Drugs for Treating and Preventing HIV Infection. 2013, Geneva, Switzerland: World Health Organisation
Ahmed S, Kim MH, Abrams EJ: Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B + approach. Curr Opin HIV AIDS. 2013, 8 (5): 474-489.
El-Khatib Z, Ekstrom AM, Coovadia A, Abrams EJ, Petzold M, Katzenstein D, Morris L, Kuhn L: Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study. BMC Public Health. 2011, 11: 88-10.1186/1471-2458-11-88.
Sherr L, Lampe FC, Clucas C, Johnson M, Fisher M, Leake Date H, Anderson J, Edwards S, Smith CJ, Hill T, Harding R: Self-reported non-adherence to ART and virological outcome in a multiclinic UK study. AIDS Care. 2010, 22 (8): 939-945. 10.1080/09540121.2010.482126.
Sabin CA, Smith CJ, d’Arminio Monforte A, Battegay M, Gabiano C, Galli L, Geelen S, Gibb D, Guiguet M, Judd A, Leport C, Dabis F, Pantazis N, Porter K, Raffi F, Thorne C, Torti C, Walker S, Warszawski J, Wintergerst U, Chene G, Lundgren J: Response to combination antiretroviral therapy: variation by age. AIDS. 2008, 22 (12): 1463-1473.
Hadland SE, Milloy MJ, Kerr T, Zhang R, Guillemi S, Hogg RS, Montaner JS, Wood E: Young age predicts poor antiretroviral adherence and viral load suppression among injection drug users. AIDS Patient Care STDS. 2012, 26 (5): 274-280. 10.1089/apc.2011.0196.
Palipudi KM, Gupta PC, Sinha DN, Andes LJ, Asma S, McAfee T, Group GC: Social determinants of health and tobacco use in thirteen low and middle income countries: evidence from Global Adult Tobacco Survey. PLoS One. 2012, 7 (3): e33466-10.1371/journal.pone.0033466.
Ironson G, Weiss S, Lydston D, Ishii M, Jones D, Asthana D, Tobin J, Lechner S, Laperriere A, Schneiderman N, Antoni M: The impact of improved self-efficacy on HIV viral load and distress in culturally diverse women living with AIDS: the SMART/EST Women’s Project. AIDS Care. 2005, 17 (2): 222-236. 10.1080/09540120512331326365.
Jones DL, Ishii Owens M, Lydston D, Tobin JN, Brondolo E, Weiss SM: Self-efficacy and distress in women with AIDS: the SMART/EST women’s project. AIDS Care. 2010, 22 (12): 1499-1508. 10.1080/09540121.2010.484454.
Johnston Roberts K, Volberding P: Adherence communication: a qualitative analysis of physician-patient dialogue. AIDS. 1999, 13: 1771-1778. 10.1097/00002030-199909100-00022.
Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, Kaplan AH, Wenger NS: A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002, 17: 756-765. 10.1046/j.1525-1497.2002.11214.x.